Project Scope

To understand the therapeutic landscape, market conditions, and treatment accessibility for sickle cell disease (SCD) in sub-Saharan Africa, guiding decisions on new product development aimed at preventing vaso-occlusive crises (VOCs) in high-burden countries

Challenge

The client seeks to comprehensively understand the therapeutic landscape, market conditions, and accessibility of SCD treatment in sub-Saharan Africa to guide new product development. Additionally, the client was focusing to identify key environmental drivers and facilitate access, taking into account the perspectives of payers, healthcare systems, providers, and patients. The objective is to create a product that prevents VOCs in high-burden countries in the region

Solution

In-depth primary research was conducted to gather understanding on:

• Current treatment options for SCD in Sub-Saharan Africa as per guidelines
• Barriers to accessing SCD treatments
• Role of government and non-governmental organizations in facilitating treatment access
• Willingness to pay for new SCD therapies and cost-effectiveness consideration
• Strategies to improve accessibility of new SCD treatments

Results

• We enabled the client to attain valuable insights into the outlined markets,
• Helped client gain clear insights into the disease burden, accessibility, unmet needs, and treatment protocols in the SCD therapy market
• Helped client gain an understanding of role of NGOs in implementation of supportive policies influencing pricing and reimbursement decisions